Diabetes
Diabetes is the major systemic cause of blindness in the western world and the incidence of blindness in people with diabetes is 20 times that of the rest of the population. Approximately 2 per cent of all people with diabetes eventually have vision which is poor enough to make them eligible for blind registration and diabetic retinopathy is the commonest cause of blind registration in people between the ages of 20 and 65 (Perry and Tullo 1995). The incidence of diabetic eye disease is closely linked to the duration and control of diabetes.
The onset of type one diabetes usually occurs in younger patients and is often fairly acute. Treatment tends to commence fairly early in the course of the disease and, if control is maintained, eye problems may be delayed for a number of years. The onset of type two diabetes, however, can be insidious and may only be recognised due to the onset of diabetic complications such as eye disease. Twenty per cent of type two diabetics have retinal changes at the time of diagnosis. The disease may have been present for quite some time, perhaps years, with multisystem complications well under way. There are many more patients with type two diabetes who have blinding eye disease, partly because of the greater numbers of people with this type of diabetes but also because of delays in diagnosis and management. Ophthalmic symptoms from diabetes are generally linked to lens or retinal problems.
Lens problems
Patients with poor glycaemic control frequently experience changes in the structure of the lens within the eye and, therefore, of the focusing power of the eye resulting in reduced vision. Temporary changes occur in the focusing power of the eye as the lens becomes slightly swollen or dehydrated due to absorbing or losing fluid by osmosis when blood glucose levels fluctuate. The most common presenting symptom associated with this is blurring of vision. This is occasionally seen as the only presenting symptom of diabetes. Patients who have diabetes newly diagnosed in A&E or in outpatient clinics should be reassured that these visual changes are temporary and that they should not visit an optometrist for an eye test clinical systemic illness New vessels at the optic disc with a haemorrhage into the retina which will significantly reduce vision This article has been subjected to double blind peer review
The effects of systemic illness on the eye and vision until their blood glucose levels have stabilised. Permanent changes in the lenscataract, can be precipitated by suddenly lowering a markedly elevated blood glucose with insulin. A rapid influx of water into the hypertonic cells in the lens as the serum osmolarity drops with the blood glucose may lead to acute swelling and permanent opacification of the lens. Cataract extraction is undertaken more frequently and at an earlier age in adult diabetics than in the general population, so cataract should be kept in mind as a possibility if a diabetic patient presents with gradual and progressive blurring of vision.
Retinal problems
Retinal problems caused by microangiopathy are the cause of most incidences of sight loss in patients with diabetes. Blood vessels in the retina are increasingly permeable, resulting in haemorrhages and exudates. Retinal ischaemia stimulates the production of vasoformative factors which result in neovascularisation. The new vessels do not have tight cell junctions and leak into the retina (retinal haemorrhage) and pre-retinal haemorrhages will leak into the vitreous (vitreous haemorrhage). Both conditions will result in loss of vision as the blood compromises the pathway for light to hit the retina.
Patients may present with sudden, painless loss of vision and any history of diabetes may suggest the possibility of haemorrhage although other causes should not be discounted. The patient is likely to be frightened about this development and may need a great deal of information and reassurance. Patients who have experienced this problem before are likely to advise A&E staff of the cause of their problem. In all cases, referral should be to an ophthalmologist although immediate treatment is unlikely to be undertaken as, if the patient cannot see out of the eye due to haemorrhage, the ophthalmologist will not be able to see enough detail in order to carry out the usual treatment, laser and will have to wait until the haemorrhage settles. Another endocrine disorder which may include eye problems as part of the disease process is malfunction of the thyroid. HYPERTHYROIDISM is caused by thyroid stimulatory immunoglobulins which are directed towards thyroid stimulating hormone receptors (Chang et al 1997) . The major abnormality in thyroid eye disease is associated with inflammation and enlargement of the orbital tissues and particularly the muscles surrounding the eye. (Onofrey et al 1998) . This may result in the eye being pushed forwards by the enlargement of the tissues in the orbit, resulting in clinical features such as discomfort and foreign body sensation, bulging or staring eyes, puffy eyelids and double vision. Loss of vision may result from compression of the optic nerve. The discomfort and grittyness is likely to be due to dry eyes caused either by incomplete lid closure because of the position of the eye (exophthalmos) or by insufficient tear production due to conjunctival involvement. Double vision is due to inflammation and fibrosis of the extraocular muscles resulting in unequal power distribution between the muscles of the two eyes. If one of the eyes Hyperthyroidism: This may result in the eye being pushed forwards by the enlargement of the tissues in the orbit, resulting in clinical features such as ... bulging or staring eyes, puffy eyelids and double vision clinical systemic illness moves more than the other, double vision will result. These ocular symptoms may be part of a pattern which includes the general symptoms of hyperthyroidism; weight loss, palpitations, tremor, tachycardia and irritability and heat intolerance. Treatment is carried out in specialist endocrine clinics but a referral to an ophthalmologist is essential in order that the ocular manifestations may be assessed and treated. Artificial tears may be prescribed to relieve dryness and if it is obvious that the lids do not close completely, and there is a possibility of corneal exposure, patients should be taught how to tape their eyelids closed at night after instillation of a bland ointment such as simple eye ointment. Eye problems are encountered less often in patients with HYPOTHYROIDISM, but this may result in lid oedema, loss of eyebrow hair, particularly of the lateral third of the eyebrows and inflammation or atrophy of the optic nerve may occur.
A number of collagen disorders have significant effects on the tissues of the eye: RHEUMATOID ARTHRITIS is linked particularly with episcleritis, keratoconjunctivitis sicca or dry eyes and inflammatory corneal ulceration. Episcleritis is generally seen as a red area on the white of the eye. It is inflammation of the top layers of the sclera and may cause irritation or aching. Although this is a self limiting condition, the unpleasant symptoms warrant referral to an ophthalmologist for treatment which is usually non steroidal anti-inflammatory drugs or drops or, less often steroid drops. Dry eyes may be a major problem for the patient and may dominate their lives. Their eyes are constantly painful, with a permanent foreign body sensation. Treatment is aimed at augmenting the tear film with artificial tears such as hypromellose or thicker solutions such as polyvinyl alcohol (such as Sno tears). The drops may be used frequently and patients should be encouraged to instil them at least hourly and by trial and error, find a time interval to which their eyes are always comfortable. The drops should not be instilled when the eye becomes gritty again, but before that stage occurs. Patients need to be aware that dry eyes do not, on the whole, resolve, but that the drops may be needed more or less frequently at different times. Inflammatory ulceration of the cornea may present major problems for sufferers of rheumatoid arthritis and progressive corneal melting may take place. Patients should be encourage to seek an ophthalmic opinion if any new eye symptoms appear or if the their dry eyes become unmanageable. ANKYLOSING SPONDYLITIS is a seronegative spondyloarthropathy which is characterised by chronic inflammation of the cartilaginous joints of the skeleton resulting particularly in fusion of the spine and sacroiliitis. Twenty five per cent of people with ankylosing spondylitis will suffer from anterior uveitis (Pavan-Langston 1996) . The most common presenting symptoms of uveitis are photophobia, pain due to iris and ciliary spasm, conjunctival redness (injection), and decreased visual acuity. The reduction in vision is due to protein and white blood cells which are part of the inflammatory reaction in the anterior chamber. The pupil, because of spasm and inflammation, is likely to be small (miosed) compared with the unaffected eye and may react sluggishly. Treatment is with steroid and mydriatic (dilating) eye drops. Uveitis is often recurrent in these patients and may be frequent so, if the patient has a recurrence of uveitis, it is likely that he or she will know -and will identify symptoms -before they are clinically visible. Ophthalmologists generally accept the patient's view of this condition and treat it before it becomes clinically obvious. It is important therefore, that patients with this condition are referred appropriately. Patients with SYSTEMIC LUPUS ERYTHEMATOSUS may develop associated conjunctivitis, episcleritis, dry eyes and/or uveitis affecting both the anterior and posterior segments of the eye.
Patients with haematological disease may present to A&E with a variety of ocular symptoms as the presenting problem. Patients with ANAEMIA may suffer repeated sub conjunctival haemorrhage. Patients with THROMBOCYTOPENIA or LEUKAEMIAS may have associated retinal oedema and haemorrhage resulting in loss of vision. SICKLE CELL DISEASE may also result in retinal and vitreous haemorrhages with symptoms of sudden reduction in vision and these patients often have comma shaped conjunctival vessels as a feature of their disease. AIDS is a multisystem disorder and, not surprisingly, it may affect the eyes. Uveitis is common and retinal haemorrhages and exudates, vasculitis and periphlebitis can all reduce vision. The HIV may produce all these Stevens Johnson syndrome showing erythema of the eyelid which arises from a serious toxic reaction to some drugs, particularly sulphonamide drugs SUE FORD/SCIENCE PHOTO LIBRARY disease processes through direct viral invasion, and immune complexes may block vessels, adding to the disease processes (Pavan-Langston 1996) . Patients with AIDS are also susceptible to opportunistic infections and, in the eye, these may include herpes simplex virus, cytomegalovirus, candida and many others, all of which are difficult to treat and all of which may seriously and quickly compromise vision -and since both eyes are often affected -independence and quality of life as well. Early treatment is essential and people with HIV must be aware that they should seek specialist medical help very quickly if symptoms appear. Moving away from disease processes, patients and A&E staff need to be aware of those disease treatments, such as drugs, which may cause ocular side effects. This list is by no means comprehensive but includes the common and the more dramatic possibilities.
Age may play a role in the effect of drugs on the eye as the reducing effectiveness of the liver and renal systems may allow higher concentrations of drugs to stay in the body; therefore ocular effects may be enhanced and toxic effects may occur. The incidence of side effects may also be genetically determined as with steroid induced raised intracellular pressure. Another example is that of Isoniazid -60 per cent of Europeans have a slow metabolisation of this drug and may experience problems such as peripheral neuropathy and optic neuritis (Vale and Cox 1985) .
Sulphonamides may precipitate severe side effects such as Stevens Johnson syndrome (erythema multiforme), as well as paralysis of the muscles surrounding the eye (the extraocular muscles), loss of depth perception, photophobia, retinal haemorrhages, optic neuritis, visual hallucinations, yellow tinted vision and cortical blindness. Many of these side effects are also seen with tetracyclines. Aminoglycosides such as gentamycin and neomycin may also cause extraocular muscle paralysis and ptosis or drooping of the upper lid may occur.
Many of the drugs used in the treatment of tuberculosis (ethambutol, rifampicin, isoniazid and streptomycin) are associated with optic neuritis, optic atrophy and colour vision disturbance. Other drugs affecting the colour vision include barbiturates, which may also cause double vision, optic neuritis, and jerky, random eye movements(nystagmus) nalidixic acid and digoxin which may cause defects in blue and yellow vision, flickering vision and haloes around lights.
Oestrogens often cause a degree of corneal oedema which may cause blurring of vision and make contact lens wear impossible. Steroids' use can lead to cataract formation and retinal oedema and anticoagulants to episodes of bleeding into ocular tissues. This may present in the form of subconjunctival haemorrhages or, more seriously, as retinal haemorrhages.
One of the most dramatic ocular problems caused by systemic drugs is oculogyric crisis in which prolonged tonic muscle contraction leads to torticollis and extraocular muscle spasm. Drugs as diverse as chloroquine (which also causes maculopathy and therefore compromised central vision), and metaclopramide may precipitate this problem but it is more often associated with phenothiazines, and particularly with tricyclic antidepressants. Resolution occurs when the drug is withdrawn and benztropine methylate (progentin) or procyclidine are also used to alleviate the problem.
Finally, alcohol causes many ocular side effects. In acute alcohol toxicity, the pupils become dilated initially, but are miosed if the patient is comatose. Visual hallucinations and colour defects may occur and the visual field may become constricted. Double vision may occur due to paralysis of the extraocular muscles. In chronic toxicity, there may be pupil miosis and the light reflex may be absent. Visual hallucinations may occur and loss of vision due to the toxic effect on the optic nerve may be reversible -or not.
Conclusion
It is useful to bear in mind that if a disease process can affect the body, it can also affect the eye to a greater or lesser degree. The awareness of the links with systemic diseases and can aid in the most effective management for this group of patients. Patients are often aware of and understand their systemic disease but find it difficult to link this to their eye problems. This sort of knowledge can not only explain present symptoms, but can help the patient to become aware of possible eye problems and what action to take should symptoms develop.
